M&A Deal Summary |
|
|---|---|
| Date | 2015-12-08 |
| Target | Forest Laboratories - Pharmaceutical Facilities |
| Sector | Packaging |
| Buyer(s) | Ropack |
| Sellers(s) | Forest Laboratories |
| Deal Type | Divestiture |
SEARCH BY
Ropack, Inc. is a provider of contract manufacturing and packaging services for the pharmaceutical and nutraceutical industries.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Packaging M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| State: New York M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2015 M&A | 1 of 1 |
| Category | Company |
|---|---|
| Founded | 1956 |
| Sector | Medical Products |
| Employees | 5,800 |
| Revenue | 3.1B USD (2013) |
Forest Laboratories, Inc. develops, manufactures, and sells branded forms of ethical drug products in the United States and Europe.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Packaging M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| State: New York M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2015 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-07-02 |
Furiex Pharmaceuticals
Morrisville, North Carolina, United States Furiex Pharmaceuticals, Inc. is a drug development company focusing on treatment for gastroenterology disorders. Furiex Pharmaceuticals forms collaborations with innovators from both the biotechnology and pharmaceutical industry. |
Buy | $1.1B |
